Quidel Corp. (QDEL)

49.90
0.10 0.20
NASDAQ : Health Technology
Prev Close 50.00
Open 49.99
Day Low/High 49.53 / 50.62
52 Wk Low/High 41.50 / 77.63
Volume 45.12K
Avg Volume 289.20K
Exchange NASDAQ
Shares Outstanding 39.34M
Market Cap 1.93B
EPS -0.20
P/E Ratio 52.81
Div & Yield N.A. (N.A)

Latest News

Quidel To Hold BNP Supply Agreement Update Conference Call On December 10, 2018

Quidel To Hold BNP Supply Agreement Update Conference Call On December 10, 2018

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will hold a conference call on December 10, 2018 to discuss the San Diego Superior Court's ruling related...

Quidel Comments On California Court Ruling

Quidel Comments On California Court Ruling

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the San Diego Superior Court (the "Court") stated that it intends to...

Quidel Receives CE Mark For TriageTrueTM High Sensitivity Troponin I Test, Its Next-Generation Diagnostic Assay For Aid In Diagnosis Of Myocardial Infarction For Use With Quidel's Triage® MeterPro Instrumented System

Quidel Receives CE Mark For TriageTrueTM High Sensitivity Troponin I Test, Its Next-Generation Diagnostic Assay For Aid In Diagnosis Of Myocardial Infarction For Use With Quidel's Triage® MeterPro Instrumented System

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received CE Mark for its TriageTrue TM High Sensitivity...

Quidel To Present At The 30th Annual Piper Jaffray Healthcare Conference

Quidel To Present At The 30th Annual Piper Jaffray Healthcare Conference

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the 30 th Annual Piper Jaffray Healthcare Conference, to be held...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMRC, ERA, HCI, MRO, PAA, PRPH, QDEL, SRE, TSLA Downgrades: ALRM, APEI, ASH, AVNS, CHUY, CTLT, HCLP, KE, MB, NKTR, NTB, TTWO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Quidel Reports Third Quarter 2018 Financial Results

Quidel Reports Third Quarter 2018 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2018.

Quidel To Hold Third Quarter 2018 Financial Results Conference Call On November 6th, 2018

Quidel To Hold Third Quarter 2018 Financial Results Conference Call On November 6th, 2018

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report third quarter 2018 financial results after market close on Tuesday, November 6, 2018.

Quidel Receives FDA Clearance, CLIA Waiver For Its Point-of-Care Sofia® 2 Lyme Fluorescent Immunoassay For Use With Sofia® 2 Instrument From Finger-Stick Whole Blood Specimens

Quidel Receives FDA Clearance, CLIA Waiver For Its Point-of-Care Sofia® 2 Lyme Fluorescent Immunoassay For Use With Sofia® 2 Instrument From Finger-Stick Whole Blood Specimens

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance and Clinical Laboratory Improvement...

Noteworthy Wednesday Option Activity: QDEL, SBUX, RESI

Noteworthy Wednesday Option Activity: QDEL, SBUX, RESI

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Quidel Corp. , where a total of 6,204 contracts have traded so far, representing approximately 620,400 underlying shares.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AXL, BIG, DK, FOSL, NFG, NKTR, SRC, TGH, UTSI Downgrades: AIRG, AXAS, HPP, PAA, QDEL, RAD Initiations: FND, RETA, TOCA Read on to get TheStreet Quant Ratings' detailed report:

Quidel Reports Second Quarter 2018 Financial Results

Quidel Reports Second Quarter 2018 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2018.

Quidel To Hold Second Quarter 2018 Financial Results Conference Call On August 7, 2018

Quidel To Hold Second Quarter 2018 Financial Results Conference Call On August 7, 2018

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report second quarter 2018 financial results after market close on Tuesday, August 7, 2018.

Quidel Receives FDA Clearance For Solana® Bordetella Complete® Molecular Diagnostic Assay For The Detection Of Pertussis (Whooping Cough), Parapertussis Infections

Quidel Receives FDA Clearance For Solana® Bordetella Complete® Molecular Diagnostic Assay For The Detection Of Pertussis (Whooping Cough), Parapertussis Infections

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance from the United States Food and Drug...

Quidel To Present At William Blair 38th Annual Growth Stock Conference

Quidel To Present At William Blair 38th Annual Growth Stock Conference

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the William Blair 38 th Annual Growth Stock Conference at the...

Quidel Announces Private Exchange Transactions

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it has entered into separate, privately negotiated exchange agreements with...

Quidel To Present At UBS Global Healthcare Conference

Quidel To Present At UBS Global Healthcare Conference

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the UBS Global Healthcare Conference at the Grand Hyatt New...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AAXN, GBLI, HAE, NWN, OXY, QDEL, TTI, ZBRA Downgrades: AC, ACM, ARMK, COKE, EDN, EPR, IT, KEYW, MG, MNTA, TEN, TRIP Initiations: DSKE, SNAP Read on to get TheStreet Quant Ratings' detailed report:

Quidel Reports First Quarter 2018 Financial Results

Quidel Reports First Quarter 2018 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2018.

QDEL Crosses Above Average Analyst Target

In recent trading, shares of Quidel Corp. have crossed above the average analyst 12-month target price of $56.00, changing hands for $56.70/share.

Quidel To Hold First Quarter 2018 Financial Results Conference Call On May 8, 2018

Quidel To Hold First Quarter 2018 Financial Results Conference Call On May 8, 2018

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report first quarter 2018 financial results after market close on Tuesday, May 8, 2018.

Quidel To Host 2018 Analyst And Investor Day In Chicago

Quidel To Host 2018 Analyst And Investor Day In Chicago

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will host its 2018 Quidel Analyst and Investor Day at the Hyatt Regency...

Quidel Announces Private Exchange Transactions

Quidel Announces Private Exchange Transactions

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it has entered into separate, privately...

Quidel Receives FDA Clearance For Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay For Use With Sofia® 2 Instrument

Quidel Receives FDA Clearance For Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay For Use With Sofia® 2 Instrument

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance from...

Quidel To Present At Upcoming Conferences

Quidel To Present At Upcoming Conferences

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the following upcoming...

Quidel Reports Fourth Quarter And Full Year 2017 Financial Results

Quidel Reports Fourth Quarter And Full Year 2017 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and year ended...

Quidel Receives 510(k) Clearance For QuickVue® Influenza A+B Test, Assay Meets FDA's Class II RIDT Requirements

Quidel Receives 510(k) Clearance For QuickVue® Influenza A+B Test, Assay Meets FDA's Class II RIDT Requirements

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance from the United...

Quidel To Hold Fourth Quarter And Full Year 2017 Financial Results Conference Call On February 21, 2018

Quidel To Hold Fourth Quarter And Full Year 2017 Financial Results Conference Call On February 21, 2018

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fourth quarter and full year 2017 financial results after...

Quidel Completes Sale Leaseback Of Summers Ridge Property For $148.65 Million

Quidel Completes Sale Leaseback Of Summers Ridge Property For $148.65 Million

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has completed the sale leaseback transaction for...

TheStreet Quant Rating: B- (Buy)